Thi, Emily P.
Lee, Amy C. H.
Geisbert, Joan B.
Ursic-Bedoya, Raul
Agans, Krystle N.
Robbins, Marjorie
Deer, Daniel J.
Fenton, Karla A.
Kondratowicz, Andrew S.
MacLachlan, Ian
Geisbert, Thomas W.
Mire, Chad E.
Article History
Received: 14 April 2016
Accepted: 14 July 2016
First Online: 22 August 2016
Competing interests
: A.L., I.M. and T.W.G. claim intellectual property regarding RNA interference for the treatment of filovirus infections. I.M. and T.W.G. are co-inventors on US patent 7,838,658 (‘siRNA silencing of filovirus gene expression’) and A.L., I.M. and T.W.G. are co-inventors on US patent 8,716,464 (‘Compositions and methods for silencing Ebola virus gene expression’). The other authors declare no competing interests. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the University of Texas Medical Branch.